TickerFactsScreenerDevelopers

EUPRAXIA PHARMACEUTICALS INC. (EPRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2022: $18.26M2023: $19.34M2024: $33.10M2025: $80.56M$80.56M
2022Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$80.56M+143.4%
2024$33.10M+71.1%
2023$19.34M+5.9%
2022$18.26M—